Quris-AI

AI-based Drug Development Platform

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2020
Total raised
$37.0M
Last: Seed 2022-12
Stage
Seed
Founded
2020
Headcount
52
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Quris-AI is an artificial intelligence innovator focused on disrupting the drug development process. The company's Bio-AI Clinical Prediction Platform is designed to accurately predict which drug candidates will safely work in humans, thereby avoiding the tremendous costs of failed clinical trials.

Quris's advanced machine-learning approach generates data for classification algorithms by testing drugs on miniaturized patients-on-a-chip, after which the machine-learning model is trained using the automatically tagged data. The generated and classified data is used to continuously retrain the algorithm, which is highly predictive of clinical safety.

Funding history · 3 rounds · $37.0M total

2022-12
Seed $9.0M
2022-01
Seed $19.0M
2021-10
Seed $9.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningSensing
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

healthcare-providersartificial-intelligencedigital-healthcarepharma-companiesmachine-learningautomationdrug-developmentpharmaceuticalssensorsnanotechnologydecision-supportmental-health